Evidence map›Paper›PMID 12881485›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

A new class of mutations reveals a novel function for the original phosphatidylinositol 3-kinase binding site.

Y Kate Hong, Aki Mikami, Brian Schaffhausen, Toni Jun, Thomas M Roberts

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Y Kate HongDepartment of Cancer Biology, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, 1 Jimmy Fund Way, Boston, MA 02115, USA.
Aki Mikami
Brian Schaffhausen
Toni Jun
Thomas M Roberts
Harvard University · USDana-Farber Cancer Institute · USTufts University · US

Funding

VIRAL ONCOPROTEIN PERTURBATION OF RB/E2F PATHWAYP01CA050661 · NCI · DANA-FARBER CANCER INSTITUTE · PI HOWLEY, PETER M · 1989 to 2013
$35.8M
Transgenic Mouse CoreP01CA089021 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SELLERS, WILLIAM R · 2001 to 2011
$20.1M
PRODUCTS OF THE TRANSFORMING GENES OF POLYOMAVIRUSR01CA034722 · NCI · TUFTS UNIVERSITY BOSTON · PI SCHAFFHAUSEN, BRIAN S · 1985 to 2015
$6.0M
MOLECULAR MECHANISMS OF POLYOMA INDUCED TRANSFORMATIONR01CA030002 · NCI · DANA-FARBER CANCER INSTITUTE · PI ROBERTS, THOMAS M · 1985 to 2014
$5.8M
PRODUCTS OF THE TRANSFORMING GENES OF POLYOMA VIRUSR37CA034722 · NCI · TUFTS UNIVERSITY BOSTON · PI SCHAFFHAUSEN, BRIAN S · 1991 to 1998
–
NCI NIH HHS CA34722NCI NIH HHS CA50661NCI NIH HHS P01 CA050661NCI NIH HHS P01 CA089021NCI NIH HHS P01 CA89021-02NCI NIH HHS R01 CA030002NCI NIH HHS R01 CA034722NCI NIH HHS R01 CA3002-21
6 · The paper itself

Abstract

Previous studies have demonstrated that the specificity of Src homology 2 (SH2) and phosphotyrosine-binding domain interactions are mediated by phosphorylated tyrosines and their neighboring amino acids. Two of the first phosphotyrosine-based binding sites were found on middle T antigen of polyoma virus. Tyr-250 acts as a binding site for ShcA, whereas Tyr-315 forms a binding site for the SH2 domain of the p85 subunit of phosphatidylinositol 3-kinase. However, genetic analysis of a given phosphotyrosine's role in signaling can be complicated when it serves as a binding site for multiple proteins. The situation is particularly difficult when the phosphotyrosine serves as a secondary binding site for a protein with primary binding determinates elsewhere. Mutation of a tyrosine residue to phenylalanine blocks association of all bound proteins. Here we show that the mutation of the amino acids following the phosphorylated tyrosine to alanine can reveal phosphotyrosine function as a secondary binding site, while abrogating the phosphotyrosine motif's role as a primary binding site for SH2 domains. We tested this methodology by using middle T antigen. Our results suggest that Tyr-250 is a secondary binding site for phosphatidylinositol 3-kinase, whereas Tyr-315 is a secondary binding site for a yet-to-be-identified protein, which is critical for transformation.

Indexed as

MutationAlanineAllelesAmino Acid SequenceAnimalsBinding SitesImmunoblottingMiceMice, Inbred BALB CMolecular Sequence DataPhenylalaninePhosphatidylinositol 3-KinasesPlasmidsPrecipitin TestsProtein BindingRetroviridaeAlaninePhenylalaninePhosphatidylinositol 3-KinasesTyrosine

Identifiers

PMID12881485
PMCPMC170936
OpenAlexW2171612012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.